This trial is enrolling 10 participants with spinal cord injury to test the safety of a cell therapy (LCTOPC1) delivered via a novel surgical device. LCTOPC1 is an experimental treatment using oligodendrocyte progenitor cells derived from human embryonic stem cells. If included, participants will receive a single injection of 10 million LCTOPC1 cells into the injured area of the spinal cord. Final assessment of safety will be performed after 3 months.
Traumatic
Type
Details
- Participants will receive a single injection of 10 million LCTOPC1 cells into the injured area of the spinal cord. - LCTOPC1 is an experimental treatment made from human embryonic stem cells. - Final assessment of safety will be performed after 3 months.
Main benefits
General health
Additional benefits
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn moreWings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more